EQT closes LSP Dementia on EUR 260m hard cap

EQT Life Sciences has closed its first dementia-focused fund on its hard cap of EUR 260m as the sector increasingly needs specialised investors, partner and head of the Dementia Fund Philip Scheltens told Unquote.